Supplementary figure shows Decr2 impacts resistance to CD8+ T cell killing in tumor models, suggesting its role in immunotherapy efficacy.
Supplementary Figure S1. Decr2 allele and expression in transplantable tumor cell models and Decr2 knockdown tumor cells were resistant to CD8+ T cell killing in vitro.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: